[阿尔茨海默病患者的发作]
S G Burd1,2, A N Bogolepova1,2, A V Lebedeva1,2
1Federal Сenter of Brain Research and Neurotechnologies, Moscow, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|December 9, 2025
概括
在阿尔茨海默病 (AD) 患者中很常见,由于诊断和疾病因素,患病率差异很大. 本综述探讨了风险因素,发作特征和阿尔茨海默病的治疗方法.
科学领域:
- 神经学 神经学
- 神经科学是一个神经科学.
- 老年病的医生 老年病的医生
背景情况:
- 神经退行性疾病经常导致晚发性发作.
- 阿尔茨海默病 (AD) 是痴呆的主要原因,与有共同的机制.
- 在现有文献中,阿尔茨海默病患者发病的患病率有很大差异.
研究的目的:
- 审查有关阿尔茨海默病患者发病率的文献.
- 分析导致广泛报告的流行数据的因素.
- 涵盖风险因素,征象学和AD相关的治疗方法.
主要方法:
- 关于阿尔茨海默病中的研究的文献综述.
- 对影响流行数据变化因素的分析.
- 综合有关风险因素,临床特征和管理的信息.
主要成果:
- 在AD患者中的患病率在报告的研究中从0.5%到64%不等.
- 变性归因于人口差异,诊断准确度,疾病特征和方法.
- 讨论了关键的风险因素,发作模式和治疗策略.
结论:
- 由于共享的病理生理机制,了解阿尔茨海默氏症中的至关重要.
- 需要进一步的研究来规范并发性和AD的诊断和治疗.
- 在阿尔茨海默病患者中治疗需要采用综合方法,考虑疾病特异性因素.
相关概念视频
Epilepsy and Seizures: Overview
1.1K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.1K
Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764
Antiepileptic Drugs: Potassium Channel Activators
611
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
611
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Antiepileptic Drugs: Glutamate Antagonists
863
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
863
Seizures: Classification
1.3K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.3K


